VDPHL01 — Topline data
H2 2026
Topline data from Study ‘304', a confirmatory Phase 3 trial evaluating the safety and efficacy of VDPHL01 in the treatment of male pattern hair loss, are expected in the second half of 2026.Source filing
MANE biotech catalysts & pipeline
VERADERMICS INC · Data as of 2026-09-08
Upcoming catalysts
VDPHL01 — Topline data
H1 2027
The Company expects to report topline data in the first half of 2027.Source filing